Drugs / Glucosamine
Glucosamine
also known as
Glucosamine sulfate · Glucosamine Hydrochloride · glucosamine sulphate · Alateris · Ardern · Bio-health · Br pharm · Chitosamine · +34 more
Trials 24
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT04994561 | Jun 2022 → Dec 2023 | — | Vitality in Aging Research Group, Inc. | Withdrawn | No outcome recorded |
| Phase 1 | NCT00833157 | Feb 2005 → Jul 2007 | osteoarthritis, knee | Bispebjerg Hospital | Unknown | Mixed |
| Phase 1 | NCT00065377 | Jul 2003 → Jun 2006 | obesity disorder | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase 22 trials · 1 met primary | ||||||
| Phase 2 | NCT06200415 | Nov 2022 → Jun 2023 | periodontitis | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT00691678 | Oct 2008 → Jul 2012 | arthropathy, breast cancer | Dawn L. Hershman | Completed | Met primary |
| Phase 36 trials · 1 met primary · 2 missed | ||||||
| Phase 3 | NCT01893905 | Jun 2013 → Aug 2014 | osteoarthritis, knee | Tedec-Meiji Farma, S.A. | Completed | Missed primary |
| Phase 3 | NCT01293305 | Nov 2011 → Aug 2012 | osteoarthritis | Azidus Brasil | Unknown | No outcome recorded |
| Phase 3 | NCT00955552 | Aug 2010 → Feb 2011 | osteoarthritis, knee | Eurofarma Laboratorios S.A. | Completed | No outcome recorded |
| Phase 3 | NCT02010918 | Feb 2009 → Nov 2010 | osteoarthritis, knee | Ache Laboratorios Farmaceuticos S.A. | Completed | No outcome recorded |
| Phase 3 | NCT00110474 | May 2000 → Dec 2002 | osteoarthritis, knee | Rottapharm | Completed | Met primary |
| Phase 3 | NCT00032890 | Apr 2000 → Feb 2004 | osteoarthritis | US Department of Veterans Affairs | Completed | Missed primary |
| Phase 411 trials · 1 met primary · 2 missed | ||||||
| Phase 4 | NCT07114016 | May 2023 → May 2025 | lichen planus, oral | Future University in Egypt | Completed | No outcome recorded |
| Phase 4 | NCT02823548 | Aug 2016 → Jun 2017 | osteoarthritis, hand | Bioiberica | Unknown | No outcome recorded |
| Phase 4 | NCT02821468 | Jun 2016 → Dec 2017 | osteoarthritis, knee | Bioiberica | Unknown | No outcome recorded |
| Phase 4 | NCT03743896 | May 2016 → Mar 2017 | osteoarthritis, knee | Lynk Biotechnologies Pte Ltd | Completed | No outcome recorded |
| Phase 4 | NCT02858297 | May 2015 → Jun 2016 | lichen planus, oral | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT01906801 | Jul 2013 → Oct 2014 | osteoarthritis, knee | Ramathibodi Hospital | Completed | Missed primary |
| Phase 4 | NCT01425853 | Sep 2011 → Apr 2013 | osteoarthritis, knee | Bioiberica | Completed | Met primary |
| Phase 4 | NCT00404079 | Dec 2006 → Aug 2009 | — | Ullevaal University Hospital | Completed | Missed primary |
| Phase 4 | NCT00317655 | Apr 2006 → Apr 2007 | — | Ferrosan AS | Completed | No outcome recorded |
| Phase 4 | NCT00294801 | Jan 2006 → Dec 2007 | osteoarthritis | Rabin Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT00251069 | Apr → Aug 2005 | osteoarthritis | Slidgigtinstituttet | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05321836 | Jul 2021 → Mar 2022 | osteoarthritis, knee | Muhammad salman, PT | Completed | No outcome recorded |
| — | NCT00086229 | Apr 2004 → Jan 2006 | osteoarthritis | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Comparator or background therapy11 trials | ||||||
| Phase 0 | NCT02214095 Comparator | Jan 2012 → Feb 2013 | chronic periodontitis | Ain Shams University | Terminated | No outcome recorded |
| Phase 3 | NCT03936192 Background | Jan 2019 → Feb 2021 | osteoarthritis, knee | Eurofarma Laboratorios S.A. | Withdrawn | No outcome recorded |
| Phase 3 | NCT02830919 Comparator | Dec 2016 → May 2019 | osteoarthritis, knee | Eurofarma Laboratorios S.A. | Completed | No outcome recorded |
| Phase 3 | NCT02448199 Comparator | Jul 2015 → Jun 2016 | osteoarthritis | Zodiac Produtos Farmaceuticos S.A. | Unknown | No outcome recorded |
| Phase 3 | NCT02306083 Comparator | Jul 2014 → Jun 2015 | — | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 3 | NCT01172249 Comparator | — | osteoarthritis, knee | Mantecorp Industria Quimica e Farmaceutica Ltd. | Unknown | No outcome recorded |
| Phase 4 | NCT02178137 Comparator | Jun 2014 → Sep 2017 | osteoarthritis, knee | Indus Hospital and Health Network | Completed | No outcome recorded |
| Phase 4 | NCT00805519 Comparator | Feb 2009 → Apr 2010 | osteoarthritis, knee | Ardabil University of Medical Sciences | Completed | No outcome recorded |
| — | NCT05212259 Comparator | Oct 2022 → Sep 2023 | arthropathy | Vedic Lifesciences Pvt. Ltd. | Unknown | No outcome recorded |
| — | NCT05223946 Background | Sep 2020 → May 2021 | — | Kyrgyz State Medical Academy | Completed | No outcome recorded |
| — | NCT02167516 Comparator | Oct 2014 → Jul 2015 | osteoarthritis, knee | The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine | Completed | No outcome recorded |
Evidence & citations 45 cited values
Every value below carries the sentence it was read from. 37 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | glucosamine | “subjects will start taking daily nutritional supplements of 1,500 mg glucosamine, 600 mg nicotinamide riboside and 500 mg trans-resveratrol” NCT04994561 ↗18“ketoprofen, tolperisone, symptomatic slow-acting drugs in osteoarthritis - SYSADOA - (glucosamine + chondroitin sulfate )” NCT05223946 ↗ “containing glucosamine an chondroitin sulfate” NCT00294801 ↗ |
| Known as | Alateris | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Ardern | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Bio-health | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Br pharm | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Chitosamine | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Chitosamine hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Cosamin | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Cozachew fizz | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Cozachew fizz combi | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Cozachew meltdown 1500 | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Cozachew meltdown combi | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | D-glucosamine hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Dolenio | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Dona | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Faximin | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Flexi-melt | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Fosachew | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Fosaveg | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | GlcN | “Glucosamine (GlcN) is an N-deacetyl amino sugar derived from the complete hydrolysis of chitosan with recently reported immunoregulatory capacity and anti-inflammatory effect” NCT02858297 ↗ |
| Known as | GlcN.H | “GlcN.H is an N-deacetyl amino sugar derived from the complete hydrolysis of chitosan” NCT07114016 ↗ |
| Known as | Glucosamina | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Glucosamine (as hydrochloride) | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Glucosamine Compound | “group I (G1) patients received 500 mg glucosamine sulphate capsules (Glucosamine Compound) , three times daily for 3 months following initial cause related therapy.” NCT02214095 ↗ |
| Known as | Glucosamine hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Glucosamine hcl meltdown | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Glucosamine Hydrochloride | “Active ingredients: Chondroitin sulfate, 200 mg and Glucosamine hydrochloride 250 mg.” NCT01425853 ↗4“Combined Chondroitin Sulfate 1200 mg + Glucosamine Hydrochloride 1500 mg” NCT02821468 ↗ “Chondroitin Sulfate 1,200mg + Glucosamine Hydrochloride 1,500mg” NCT02823548 ↗ |
| Known as | Glucosamine sulf | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Glucosamine sulfate | “a new formulation of a fixed dose combination of glucosamine sulfate (GS; 1500 mg) and bovine chondroitin sulfate (CS; 1200 mg)” PMID 33468249 ↗ Jan 20218“Oral intake of 1500 mg glucosamine sulfate(from Pharma Nord) daily for 6 months” NCT00404079 ↗ “chondroitin sulfate (CS) and glucosamine sulfate (GS)” PMID 27477804 ↗ Jan 2017 |
| Known as | GLUCOSAMINE SULFATE POTASSIUM CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Glucosamine sulfate salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | GLUCOSAMINE SULFATE SODIUM CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | glucosamine sulphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02214095 ↗ |
| Known as | Glusartel | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Gosachew | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Gosaveg | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Joint-flex daily | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Mediflex | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | NSC-234443 | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | NSC-758 | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | pCGS | “Patented crystalline glucosamine sulfate (pCGS) and diacerein monotherapy have been recommended for treatment of mild to moderate osteoarthritis (OA), but evidence of efficacy...” PMID 27729073 ↗ Oct 2016 |
| Known as | Pro coxam | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Known as | Tiocondramina | ChEMBL registry synonym — accepted as the source's own label CHEMBL493287 ↗ |
| Modality | Small molecule | “Glucosamine (GlcN) is an N-deacetyl amino monosaccharide sugar” NCT06200415 ↗ |
| Route | Oral | “oral glucosamine” NCT00065377 ↗ |